Investors Are Betting Big Against Marijuana Stock Insys Therapeutics

By:
Investors Are Betting Big Against Marijuana Stock Insys Therapeutics

Flickr / EnriqueMendez / CC BY-NC-SA 2.0.

As of April 13, 2017, more than 10.4 million shares of Insys Therapeutics (NASDAQ: INSY) were sold short. That’s 44% of the marijuana stock’s float. Investors have clearly bet big against Insys, anticipating that the stock will sink.

However, that pessimism could be very short-sighted. Here’s why investors betting against Insys are wrong about the marijuana stock’s prospects.

Potential end in sight for federal Subsys probe

Some short-sellers might have been counting on federal and state probes into Insys’ sales and marketing practices.

View Original Article Here

Repost is the designation for articles collected from the Internet whose content may interest our readers. These articles are not written by our staff and they do not necessarily reflect our views.

Related posts

Top